9.B.87.1.31 CD44 of 742 aas and 2 TMSs, N- and C-terminal. It is a cell-surface
receptor that plays a role in cell-cell interactions, cell adhesion and
migration, helping the cells to sense and respond to changes in the tissue
microenvironment (Crosby et al. 2009, Yoshida et al. 2012). It participates thereby in a wide variety of cellular functions including
the activation, recirculation and homing of T-lymphocytes,
hematopoiesis, inflammation and response to bacterial infection (Funaro et al. 1994). CD44 enhances Na+/H+ exchanger isoform-1 (NHE1) activity, causing ECM remodeling and tumor invasion (Suleiman et al. 2018). Transmembrane proteins, CD51/61 and CD44 facilitate cell adhesion, and are commonly found on the surfaces of cancer cells (Mori et al. 2023). It may play a role in osteoporosis (Wu et al. 2023). CD44 regulates Epac1-mediated beta-adrenergic-receptor-induced Ca2+-handling abnormalities implicated in cardiac arrhythmias (Chan et al. 2023). CD44 is a single-chain transmembrane receptor that exists in multiple forms due to alternative mRNA splicing and post-translational modifications. CD44 is the main cell surface receptor for hyaluronan as well as other extracellular matrix molecules, cytokines, and growth factors that play important roles in physiological processes (such as hematopoiesis and lymphocyte homing) and the progression of various diseases, the predominant one being cancer (Skandalis 2023). The CD44 intracellular domain interacts with various cytoplasmic effectors regulating cell-trafficking machinery, signal transduction pathways, the transcriptome, and vital cell metabolic pathways (Skandalis 2023).
|
Accession Number: | P16070 |
Protein Name: | CD44 antigen |
Length: | 742 |
Molecular Weight: | 81538.00 |
Species: | Homo sapiens (Human) [9606] |
Number of TMSs: | 1 |
Location1 / Topology2 / Orientation3: |
Cell membrane1 / Single-pass type I membrane protein2 |
Substrate |
|
---|
1: MDKFWWHAAW GLCLVPLSLA QIDLNITCRF AGVFHVEKNG RYSISRTEAA DLCKAFNSTL
61: PTMAQMEKAL SIGFETCRYG FIEGHVVIPR IHPNSICAAN NTGVYILTSN TSQYDTYCFN
121: ASAPPEEDCT SVTDLPNAFD GPITITIVNR DGTRYVQKGE YRTNPEDIYP SNPTDDDVSS
181: GSSSERSSTS GGYIFYTFST VHPIPDEDSP WITDSTDRIP ATTLMSTSAT ATETATKRQE
241: TWDWFSWLFL PSESKNHLHT TTQMAGTSSN TISAGWEPNE ENEDERDRHL SFSGSGIDDD
301: EDFISSTIST TPRAFDHTKQ NQDWTQWNPS HSNPEVLLQT TTRMTDVDRN GTTAYEGNWN
361: PEAHPPLIHH EHHEEEETPH STSTIQATPS STTEETATQK EQWFGNRWHE GYRQTPKEDS
421: HSTTGTAAAS AHTSHPMQGR TTPSPEDSSW TDFFNPISHP MGRGHQAGRR MDMDSSHSIT
481: LQPTANPNTG LVEDLDRTGP LSMTTQQSNS QSFSTSHEGL EEDKDHPTTS TLTSSNRNDV
541: TGGRRDPNHS EGSTTLLEGY TSHYPHTKES RTFIPVTSAK TGSFGVTAVT VGDSNSNVNR
601: SLSGDQDTFH PSGGSHTTHG SESDGHSHGS QEGGANTTSG PIRTPQIPEW LIILASLLAL
661: ALILAVCIAV NSRRRCGQKK KLVINSGNGA VEDRKPSGLN GEASKSQEMV HLVNKESSET
721: PDQFMTADET RNLQNVDMKI GV